Treatment of Unresectable Hepatocellular Carcinoma with Use of 90Y Microspheres (TheraSphere): Safety, Tumor Response, and Survival

Seeff, 2004, Introduction: the burden of hepatocellular carcinoma, Gastroenterology, 127, S1, 10.1053/j.gastro.2004.09.010

Carr, 2004, Hepatocellular carcinoma: current management and future trends, Gastroenterology, 127, S218, 10.1053/j.gastro.2004.09.036

Huang, 1992, Overexpression of the MDR1 gene and P-glycoprotein in human hepatocellular carcinoma, J Natl Cancer Inst, 84, 262, 10.1093/jnci/84.4.262

Soini, 1996, Expression of P-glycoprotein in hepatocellular carcinoma: a potential marker of prognosis, J Clin Pathol, 49, 470, 10.1136/jcp.49.6.470

Stillwagon, 1989, 194 hepatocellular cancers treated by radiation and chemotherapy combinations: toxicity and response. A Radiation Therapy Oncology Group study, Int J Radiat Oncol Biol Phys, 17, 1223, 10.1016/0360-3016(89)90530-0

Dawson, 2003, Conformal chemoradiation for primary and metastatic liver malignancies, Semin Surg Oncol, 21, 249, 10.1002/ssu.10043

Rilling, 2002, Multidisciplinary management of hepatocellular carcinoma, J Vasc Interv Radiol, 13, S259, 10.1016/S1051-0443(07)61794-1

Head, 2004, Thermal ablation for hepatocellular carcinoma, Gastroenterology, 127, S167, 10.1053/j.gastro.2004.09.031

Bruix, 2004, Chemoembolization for hepatocellular carcinoma, Gastroenterology, 127, S179, 10.1053/j.gastro.2004.09.032

Kennedy, 2004, Pathologic response and microdosimetry of yttrium-90 microspheres in man: review of four explanted whole livers, Int J Radiat Oncol Biol Phys, 60, 1552, 10.1016/j.ijrobp.2004.09.004

Yorke, 1999, Can current models explain the lack of liver complication in Y-90 microsphere therapy?, Clin Cancer Res, 5, 3024s

Russell, 1988, Dosimetry calculations for yttrium-90 used in the treatment of liver cancer, Endocuriether Hypertherm Oncol, 4, 171

Salem, 2002, Yttrium-90 microspheres: radiation therapy for unresectable liver cancer, J Vasc Interv Radiol, 13, S223, 10.1016/S1051-0443(07)61790-4

Dancey, 2000, Treatment of nonresectable hepatocellular carcinoma with intrahepatic yttrium-90 microspheres, J Nucl Med, 41, 1673

Goin, 2005, Treatment of unresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres: a risk stratification analysis, J Vasc Interv Radiol, 16, 195, 10.1097/01.RVI.0000142602.79459.90

Goin, 2005, Treatment of unresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres: factors associated with liver toxicities, J Vasc Interv Radiol, 16, 205, 10.1097/01.RVI.00001142592.89564.F9

Geschwind, 2004, Yttrium-90 microspheres for the treatment of hepatocellular carcinoma, Gastroenterology, 127, S194, 10.1053/j.gastro.2004.09.034

Child, 1964, Surgery and portal hypertension, 1950

Pugh, 1973, Transection of the oesophagus for bleeding oesophageal varices, Br J Surg, 60, 646, 10.1002/bjs.1800600817

Okuda, 1985, Natural history of hepatocellular carcinoma and prognosis in relation to treatment: study of 850 patients, Cancer, 56, 918, 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E

1998, A new prognostic system for hepatocellular carcinoma: a retrospective study of 435 patients, Hepatology, 28, 751, 10.1002/hep.510280322

Bruix, 2001, Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona–2000 EASL Conference, J Hepatol, 35, 421, 10.1016/S0168-8278(01)00130-1

Therasse, 2000, New guidelines to evaluate the response to treatment in solid tumors, J Natl Cancer Inst, 92, 205, 10.1093/jnci/92.3.205

1999

Kaplan, 1958, Nonparametric estimation from incomplete observations, J Am Stat Assoc, 53, 457, 10.2307/2281868

Cox, 1984

Wolfe, 1973, 114

Diggle, 1994

Hardin, 2003

Lipsitz, 1991, Generalized estimating equations for correlated binary data: using the odds ratio as a measure of association, Biometrika, 78, 153, 10.1093/biomet/78.1.153

Nowak, 2004, Systemic therapy for advanced hepatocellular carcinoma: a review, Eur J Cancer, 40, 1474, 10.1016/j.ejca.2004.02.027

Johnson, 2002, Hepatocellular carcinoma: Is current therapy really altering outcome?, Gut, 51, 459, 10.1136/gut.51.4.459

Cusnir, 2004, Novel systemic therapy options for hepatocellular carcinoma, Cancer J, 10, 97, 10.1097/00130404-200403000-00005

Lo, 2002, Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma, Hepatology, 35, 1164, 10.1053/jhep.2002.33156

Llovet, 2002, Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial, Lancet, 359, 1734, 10.1016/S0140-6736(02)08649-X

1995, A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma, N Engl J Med, 332, 1256, 10.1056/NEJM199505113321903

Raoul, 1997, Prospective randomized trial of chemoembolization versus intra-arterial injection of I-131 labeled iodized oil in the treatment of hepatocellular carcinoma, Hepatology, 26, 1156

Ebied, 2003, Evaluation of responses to chemoembolization in patients with unresectable hepatocellular carcinoma, Cancer, 97, 1042, 10.1002/cncr.11111

Carr, 2004, Hepatic arterial 90yttrium glass microspheres (TheraSphere) for unresectable hepatocellular carcinoma: interim safety and survival data on 65 patients, Liver Transpl, 10, S107, 10.1002/lt.20036

Wong, 2004, Pretransplant treatment of hepatocellular carcinoma: Assessment of tumor necrosis in explanted livers, Clin Transplant, 18, 227, 10.1111/j.1399-0012.2004.00164.x

Bruix, 1998, Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution, Hepatology, 27, 1578, 10.1002/hep.510270617

Huo, 2004, Induction of complete tumor necrosis may reduce intrahepatic metastasis and prolong survival in patients with hepatocellular carcinoma undergoing locoregional therapy: a prospective study, Ann Oncol, 15, 775, 10.1093/annonc/mdh184

Anderson, 1983, Analysis of survival by tumor response, J Clin Oncol, 11, 710, 10.1200/JCO.1983.1.11.710

Andrews, 1994, Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up, J Nucl Med, 35, 1637

Safaraz, 2003, Physical aspects of yttrium-90 microsphere therapy for nonresectable hepatic tumors, Med Phys, 30, 199, 10.1118/1.1538235

Lopez, 2002, Comparison of transarterial chemoembolization in patients with unresectable, diffuse vs focal hepatocellular carcinoma, Arch Surg, 137, 653, 10.1001/archsurg.137.6.653

Kanematsu, 2003, Hepatocellular carcinoma of diffuse type: MR imaging findings and clinical manifestations, J Magn Reson Imaging, 18, 189, 10.1002/jmri.10336